BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15927197)

  • 1. The detection of anti-erythropoietin antibodies in human serum and plasma: part II. Validation of a semi-quantitative 3H-thymidine uptake assay for neutralizing antibodies.
    Kelley M; Cooper C; Matticoli A; Greway A
    J Immunol Methods; 2005 May; 300(1-2):179-91. PubMed ID: 15927197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a cell-based bioassay for the detection of neutralizing antibodies against recombinant human erythropoietin in clinical studies.
    Wei X; Swanson SJ; Gupta S
    J Immunol Methods; 2004 Oct; 293(1-2):115-26. PubMed ID: 15541282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of neutralizing antibodies to erythropoietin by inhibition of rHuEPO-stimulated EGR1 gene expression in the UT-7/EPO cell line.
    Ferguson J; Bird C; Wadhwa M; Burns C
    J Immunol Methods; 2013 Jan; 387(1-2):191-8. PubMed ID: 23142458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and characterization of antibodies against recombinant human erythropoietin by RIPA, ELISA and neutralization assay in patients with renal anemia.
    Gross J; Moller R; Bischoff S; Canaan-Kühl S; Fromme M; Henke W
    J Immunol Methods; 2008 Jul; 336(2):152-8. PubMed ID: 18501920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy to confirm the presence of anti-erythropoietin neutralizing antibodies in human serum.
    Sanchez S; Barger T; Zhou L; Hale M; Mytych D; Gupta S; Swanson SJ; Civoli F
    J Pharm Biomed Anal; 2011 Jul; 55(5):1265-74. PubMed ID: 21497040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a bridging ELISA for detection of anti-erythropoietin binding antibodies and a cell-based bioassay for neutralizing antibodies in human sera.
    Shin SK; Ha SK; Lee KW; Yoo TH; Yun SR; Yoon SH; Kim SJ; Lee SK; Heo TH
    J Pharm Biomed Anal; 2010 Jun; 52(2):289-93. PubMed ID: 20133098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possible role of soluble erythropoietin receptors in renal anemia].
    Sakaguchi M; Maeda Y; Naiki Y; Hasegawa H; Kanamaru A
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):524-9. PubMed ID: 12476588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation.
    Ruscetti SK
    J Natl Cancer Inst; 1986 Jul; 77(1):241-5. PubMed ID: 3459916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a chemiluminescent imaging assay for the detection of anti-erythropoietin antibody in human sera.
    Wang W; Lu Y; Zhang S; Wang S; Cao P; Tian Y; Zhang X
    Luminescence; 2009; 24(1):55-61. PubMed ID: 18780331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures.
    Thorpe R; Swanson SJ
    Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv16-22. PubMed ID: 15827053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay.
    Tacey R; Greway A; Smiell J; Power D; Kromminga A; Daha M; Casadevall N; Kelley M
    J Immunol Methods; 2003 Dec; 283(1-2):317-29. PubMed ID: 14659922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients.
    Nakao K; Wada J; Ota K; Ichikawa H; Akagi S; Okamoto A; Hida K; Nagake Y; Makino H
    Am J Kidney Dis; 2003 Mar; 41(3):624-36. PubMed ID: 12612986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo model to assess factors that may stimulate the generation of an immune reaction to erythropoietin.
    Ryan MH; Heavner GA; Brigham-Burke M; McMahon F; Shanahan MF; Gunturi SR; Sharma B; Farrell FX
    Int Immunopharmacol; 2006 Apr; 6(4):647-55. PubMed ID: 16504928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing.
    Mytych DT; Barger TE; King C; Grauer S; Haldankar R; Hsu E; Wu MM; Shiwalkar M; Sanchez S; Kuck A; Civoli F; Sun J; Swanson SJ
    J Immunol Methods; 2012 Aug; 382(1-2):129-41. PubMed ID: 22634015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera.
    Hoesel W; Gross J; Moller R; Kanne B; Wessner A; Müller G; Müller A; Gromnica-Ihle E; Fromme M; Bischoff S; Haselbeck A
    J Immunol Methods; 2004 Nov; 294(1-2):101-10. PubMed ID: 15604020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
    Woodburn KW; Fan Q; Winslow S; Chen MJ; Mortensen RB; Casadevall N; Stead RB; Schatz PJ
    Exp Hematol; 2007 Aug; 35(8):1201-8. PubMed ID: 17662888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-EPO antibodies in human sera by a bridging ELISA is much more sensitive when coating biotinylated rhEPO to streptavidin rather than using direct coating of rhEPO.
    Gross J; Moller R; Henke W; Hoesel W
    J Immunol Methods; 2006 Jun; 313(1-2):176-82. PubMed ID: 16740273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
    Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
    Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of erythropoietin stimulatory activity using [3H]thymidine uptake by K562 cells.
    Lewis JP; McKie VC; Faguet GB; Felice AE
    Exp Hematol; 1989 Feb; 17(2):102-5. PubMed ID: 2912736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of neutralizing anti-therapeutic protein antibodies in serum or plasma samples containing high levels of the therapeutic protein.
    Lofgren JA; Wala I; Koren E; Swanson SJ; Jing S
    J Immunol Methods; 2006 Jan; 308(1-2):101-8. PubMed ID: 16356511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.